Contact Cast Versus Posterior Slab as Offloading Modality for Charcot Neuroarthropathy

计划入组 80 人 · 首次发布于 2024 年 8 月 27 日

Efficacy of Teriparatide in Diabetic Inactive Charcot Neuroarthropathy of Foot

计划入组 20 人 · 首次发布于 2013 年 12 月 30 日

Clinico-Radiological Characterisation for Remission of Acute Charcot-Neuroarthropathy of Foot.

计划入组 25 人 · 首次发布于 2023 年 8 月 30 日

Charcot-Marie-Tooth Disease Type 1A(Metagenomi)

Charcot Marie Tooth -Type 2A (MitoRx Therapeutics)

Beclin activator peripheral (Charcot Marie Tooth disease type 1A)

GROUPE HOSPITALIER DU HAVRE

France

CHARIOT PHARMA LIMITED

Hong Kong, China

Carmot Therapeutics, Inc.

United States

GLP-1 Receptor Agonists Linked to Fewer Diabetic Foot Ulcers but Higher Charcot Risk Than DPP-4 Inhibitors

Augustine Therapeutics Secures €78 Million to Advance HDAC6 Inhibitor for Charcot-Marie-Tooth Disease

Advancements in Clinical Outcome Assessments and Biomarkers Pave the Way for CMT Treatment